A Pilot Study to Explore a Potential Role of Nitazoxanide (NTZ) in the Prevention of Recurrent Hepatitis C Virus (HCV) Infection After Orthotopic Liver Transplantation.
Phase of Trial: Phase I
Latest Information Update: 30 Jul 2012
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 06 Jun 2011 Actual end date (January 2011) added as reported by ClinicalTrials.gov.
- 06 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Mar 2010 New trial record